Pharmaceutical Regulations in Japan
[Pages:35]Pharmaceutical Regulations in Japan
Tamiji Nakanishi Evaluation and Licensing Division, Pharmaceutical
and Food Safety Bureau, Ministry of Health, Labour and Welfare
* A Japanese translation is the official edition.
Today's contents
Drug manufacturing/marketing
Accreditation of foreign manufacturer and GMP compliance review
Accreditation of foreign manufacturer GMP compliance review in Regulatory review
Drug Substance Master File (MF)
DRUG MANUFACTURING/MARKETING
Regulations Related to Drug Manufacturing/Marketing
Manufacturing/marketing refers to selling or delivering the manufactured (including commissioned manufacturing) or imported drugs (excluding drug substance).
There are various provisions in the Pharmaceutical Affairs Law so that the drug manufacturer/market authorization holder takes all responsibilities from manufacturing to post-marketing affairs.
Collaboration between Marketing Approval Holders and Manufacturers
Marketing authorization holders
General marketing manager
Quality Assurance Department (GQP)
Quality Assurance Manager
Collaborate
Safety Control management department (GVP)
Safety Control Manager
Agreement, manufacturing monitoring
Product delivery
Manufacturers
Product Security Pharmacist (responsible person of manufacturing site)
Manufacturing Department
Responsible person for manufacturing
Quality Department
Responsible person for quality control and assurance
Determination of release to the Manufacturing manager (market
Note: Determination of release to the market is a task of marketing authorization holders, but is usually entrusted with manufacturers.
For the marketing of pharmaceutical products
License of manufacturer/market authorization holder is necessary.
Obtain license by demonstrating that the business entity is capable of responsible manufacturing, quality control and post-marketing safety control of pharmaceutical products.
License (accreditation ) of manufacturer is necessary.
License (accreditation ) of manufacturer is obtained by showing that the party concerned has capacity to manufacture drugs.
Manufacturing/marketing approval is necessary.
It is necessary to collect the data related to drug quality, efficacy and safety and have those reviewed and approved by the Minister of Health, Labour and Welfare.
6
Marketing approval requirements for pharmaceutical products (Section 2, Article 14 of the Law)
License of manufacturer/market authorization holder
License (accreditation ) of manufacturer at the manufacturing site
Absence of problems in drug quality, efficacy and safety
Compliance with Good Manufacturing Practice (GMP) at the manufacturing site
7
ACCREDITATION OF FOREIGN MANUFACTURER AND GMP COMPLIANCE REVIEW
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- prescription drug list by tier
- gao 15 85 compounded drugs payment practices vary
- stability indicating methods
- bayer back body
- drug facts nauzene
- gluten in medications beyond celiac
- drug facts continued active ingredients purpose 1
- fda proposed guidance document compounding animal
- midol complete caplets bayer
- vaccine excipient summary excipients included in u s
Related searches
- group home regulations in nevada
- teaching english in japan requirements
- assisted living regulations in nevada
- what are regulations in business
- top pharmaceutical companies in california
- largest pharmaceutical distributors in usa
- pharmaceutical manufacturers in usa
- top pharmaceutical companies in the world
- pharmaceutical companies in india
- pharmaceutical jobs in new jersey
- deer hunting regulations in florida
- pharmaceutical companies in nj hiring